Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 3 (2006), Issue 12 (December)

1. Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis.
   Virol J, 3: 98. [Abstract] [Full-text]
2. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
   Hepatology, 44(6): 1511-7. [Abstract] [Full-text]
3. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
   Hepatology, 44(6): 1555-63. [Abstract] [Full-text]
4. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.
   Hepatology, 44(6): 1543-54. [Abstract] [Full-text]
5. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
   Hepatology, 44(6): 1441-51. [Abstract] [Full-text]
6. JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinase-independent phosphorylation.
   Hepatology, 44(6): 1432-40. [Abstract] [Full-text]
7. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
   Hepatology, 44(6): 1648-55. [Abstract] [Full-text]
8. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment.
   Hepatology, 44(6): 1564-71. [Abstract] [Full-text]
9. Hyponatremia in cirrhosis: Results of a patient population survey.
   Hepatology, 44(6): 1535-42. [Abstract] [Full-text]
10. Expression of inducible nitric oxide (NO) synthase but not prevention by its gene ablation of hepatocarcinogenesis with fibrosis caused by a choline-deficient, L-amino acid-defined diet in rats and mice.
    Nitric Oxide, 16(1): 164-76. [Abstract] [Full-text]
11. Basal reactive oxygen species determine the susceptibility to apoptosis in cirrhotic hepatocytes.
    Free Radic Biol Med, 41(11): 1645-54. [Abstract] [Full-text]
12. The role of monocyte chemoattractant protein-1 in biliary atresia.
    J Pediatr Surg, 41(12): 1967-72. [Abstract] [Full-text]
13. Esophageal varices in cirrhotic patients: evaluation with liver CT.
    AJR Am J Roentgenol, 188(1): 139-44. [Abstract] [Full-text]
14. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection.
    J Infect Dis, 195(2): 288-95. [Abstract] [Full-text]
15. Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.
    Hepatology, 45(1): 242-9. [Abstract] [Full-text]
16. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
    Hepatology, 45(1): 213-22. [Abstract] [Full-text]
17. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
    Hepatology, 45(1): 118-27. [Abstract] [Full-text]
18. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.
    Hepatology, 45(1): 223-9. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.